| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.55 | $49.39 (0%) | 🛒 Add to cart |
| 180 | $0.41 | $98.79 $73.59 (26%) | 🛒 Add to cart |
| 270 | $0.37 | $148.18 $99.80 (33%) | 🛒 Add to cart |
| 360 | $0.34
Best per pill | $197.58 $121.97 (38%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.38 | $67.54 (0%) | 🛒 Add to cart |
| 270 | $0.33 | $101.31 $88.71 (12%) | 🛒 Add to cart |
| 360 | $0.31
Best per pill | $135.08 $110.88 (18%) | 🛒 Add to cart |
Similar products
More info:
Diclofenac: Potent Anti-inflammatory and Analgesic Relief for Musculoskeletal Pain - Evidence-Based Review
Diclofenac represents one of the most widely prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) globally, available in oral, topical, and injectable formulations. As a phenylacetic acid derivative, it primarily functions through potent cyclooxygenase (COX) inhibition, providing both anti-inflammatory and analgesic effects. Its therapeutic profile makes it particularly valuable for managing acute and chronic pain conditions, though its risk-benefit profile requires careful clinical consideration. 1. Introduction: What is Diclofenac? Its Role in Modern Medicine Diclofenac stands as a cornerstone in pain management protocols worldwide, belonging to the NSAID class that revolutionized inflammatory condition treatment.
aldara cream
Aldara Cream represents one of those fascinating immunomodulators that really changed how we approach certain dermatological conditions. It’s a topical cream containing 5% imiquimod as the active ingredient, classified as an immune response modifier rather than a traditional cytotoxic agent. What makes it particularly valuable in clinical practice is its ability to stimulate the body’s own immune system to recognize and attack abnormal cells, making it especially useful for treating various skin conditions where viral pathogens or dysplastic cells are involved.
arcoxia
Arcoxia represents a significant advancement in the COX-2 selective NSAID class, offering targeted pain relief with potentially improved gastrointestinal safety compared to traditional nonsteroidal anti-inflammatory drugs. This etoricoxib-based medication has established itself as a valuable option for managing various inflammatory conditions while minimizing certain adverse effects associated with older NSAIDs. 1. Introduction: What is Arcoxia? Its Role in Modern Medicine Arcoxia (etoricoxib) belongs to the selective cyclooxygenase-2 (COX-2) inhibitor class of nonsteroidal anti-inflammatory drugs (NSAIDs).
Celebrex: Targeted Pain Relief and Inflammation Control - Evidence-Based Review
Celebrex, known generically as celecoxib, is a prescription nonsteroidal anti-inflammatory drug (NSAID) belonging to the COX-2 selective inhibitor class. It’s formulated in capsule form, typically 100 mg, 200 mg, and 400 mg strengths, and is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain. Unlike traditional NSAIDs like ibuprofen or naproxen, which inhibit both COX-1 and COX-2 enzymes, celecoxib specifically targets the COX-2 enzyme responsible for inflammation and pain, potentially reducing the risk of gastrointestinal side effects.
emulgel
An emulgel represents a sophisticated hybrid topical delivery system that combines the characteristics of both emulsions and gels. This advanced formulation has gained significant traction in dermatology, sports medicine, and pain management due to its unique ability to enhance drug penetration while providing excellent patient compliance. Unlike traditional creams or ointments, emulgels offer superior stability, controlled release properties, and enhanced bioavailability of active pharmaceutical ingredients through the skin barrier. The fundamental structure consists of an emulsion system—typically oil-in-water or water-in-oil—dispersed within a gel matrix.
etodolac
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) belonging to the pyranocarboxylic acid class, prescribed primarily for its analgesic and anti-inflammatory properties in managing osteoarthritis and rheumatoid arthritis. Unlike many older NSAIDs, etodolac demonstrates relative COX-2 selectivity, which contributes to its favorable gastrointestinal tolerability profile while maintaining potent inhibition of prostaglandin synthesis. Available in both immediate and extended-release formulations, this medication occupies an important niche in pain management protocols, particularly for patients requiring long-term anti-inflammatory therapy with reduced ulcerogenic risk compared to non-selective agents.
feldene
Feldene, known generically as piroxicam, represents one of the older nonsteroidal anti-inflammatory drugs (NSAIDs) in the oxicam class. Initially developed by Pfizer and approved by the FDA in the early 1980s, it’s available in oral capsules and as a topical gel in some markets. What’s interesting about Feldene isn’t just its mechanism—which we’ll get into—but its particular pharmacokinetic profile that gives it both advantages and limitations in clinical practice. Many clinicians remember it as the “once-daily NSAID” when it first launched, though its use has declined with newer agents and safety concerns.
imiquad cream
Imiquad cream represents one of those rare instances where a topical immunomodulator actually delivers on its theoretical promise. When I first encountered this formulation during my dermatology residency back in 2012, I’ll admit I was skeptical - we’d seen plenty of “breakthrough” topicals that ultimately disappointed in clinical practice. But this 5% imiquimod cream formulation demonstrated something different right from the start, particularly for our patients with actinic keratoses who’d failed conventional therapies.
Imusporin: Targeted Immune System Modulation for Chronic Inflammation
Product Description Imusporin represents a novel class of immunomodulatory nutraceuticals, specifically formulated to recalibrate the immune system’s response. It’s not a simple immune booster, which can be problematic in autoimmune conditions, but rather a sophisticated blend of bioactive compounds designed to promote immune homeostasis. We initially conceptualized it after observing consistent patterns of subclinical inflammation in patients with chronic fatigue that didn’t fit classic autoimmune diagnoses. The development wasn’t straightforward; our pharmacologist, Dr.